Quantcast

Latest CFA Institute Stories

2014-05-13 08:31:13

NEW YORK, May 13, 2014 /PRNewswire/ -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) is a development stage biopharmaceutical company that is primarily engaged in developing oncology and dermatology therapies through its two predominant drug candidates, PV-10 and PH-10. The company is working to develop PV-10 for the treatment of several life-threatening cancers, including metastatic melanoma, liver cancer (also known as Hepatocellular carcinoma, or HCC), and breast cancer....

2014-05-12 08:27:09

NEW YORK, May 12, 2014 /PRNewswire/ -- Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) Today, approximately 8% of the world's population is over the age of 65; and that number is expected to double in less than 40 years. As the world's population ages in the coming years, the demand for critical care services will undoubtedly increase in both developed and underdeveloped countries across the world. In fact, GBI Research estimates that the size of this market will grow from $2.3 billion in...

2014-04-11 08:24:22

NEW YORK, April 11, 2014 /PRNewswire/ -- Navidea Pharmaceuticals, Inc. (NYSEMKT: NAVB), is a biopharmaceutical company that is focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Its core product, Lymphoseek, a small-molecule radiopharmaceutical used in lymphatic mapping procedures, helps physician identify and target the lymph nodes that drain from a primary tumor that contain cancer cells. The U.S. Food and Drug...

2014-03-27 08:29:37

NEW YORK, March 27, 2014 /PRNewswire/ -- Across the globe, there are over 13 million new cancer cases each year. By 2030, it is estimated by the International Agency for Research on Cancer (IARC) that there will be approximately 21.4 million new cancer cases and 13.2 million cancer deaths worldwide. Some of the more common (and deadly) forms of cancer are head and neck cancer, which account for approximately 600,000 new cases worldwide each year and result in a five-year survival rate...

2014-03-20 23:30:49

Douglas Lyons of Douglas J Lyons Financial Group achieves important designation of Certified Divorce Financial Analyst™. Red Bank, NJ (PRWEB) March 20, 2014 Douglas J Lyons recently completed a specialized educational program in professional divorce analysis and is now a Certified Divorce Financial Analyst™. Mr. Lyons is trained to provide financial information and assistance to people going through a divorce. He evaluates the tax implications of dividing property and the financial...

2014-03-13 12:25:13

NEW YORK, Feb. 27, 2014 /PRNewswire/ -- Provectus Pharmaceuticals, Inc. (OTC: PVCT) The melanoma version of the drug is the closest to market release. Phase 2 data was finalized in October 2012 and the drug is being prepped for Breakthrough Therapy Designation (BTD) Drug Submission with the FDA and is in the final steps for approval. Once submitted PVCT should receive a decision within 60 days of receipt of that request. The breast and liver cancer versions of the drug have...

2014-02-27 08:25:52

NEW YORK, Feb. 27, 2014 /PRNewswire/ -- Provectus Pharmaceuticals, Inc. (OTC: PVCT) The melanoma version of the drug is the closest to market release. Phase 2 data was finalized in October 2012 and the drug is being prepped for Breakthrough Therapy Designation (BTD) Drug Submission with the FDA and is in the final steps for approval. Once submitted PVCT should receive a decision within 60 days of receipt of that request. The breast and liver cancer versions of the drug have...

2014-02-24 23:03:33

Fordham team advances to Americas Regional to present their research on Colgate-Palmolive in Denver, CO. New York, NY (PRWEB) February 24, 2014 Fordham University was selected as the winner of the New York Local Final of the CFA Institute Research Challenge®, hosted by the New York Society of Security Analysts in New York City on February 20, 2014. Charmian Cooper, Neil Dhruve, Matthew Henriksson, Frank Kong, and Prapunsak (Ta) Wongpaitoon led Fordham to the title. They competed...

2014-02-17 08:24:57

NEW YORK, Feb. 17, 2014 /PRNewswire/ -- With the tremendous run in the biotech sector over the last 12 months many have overlooked this micro-cap gem that has terrific upside potential. Metastat, Inc. (OTCQB: MTST) is a life sciences company that provides proprietary platform technologies for the treatment of systemic metastasis. This micro-cap stock is topping the list for many analyst in the coming year. Metastat has all characteristics that a smart investor would look for in a...

2014-02-11 23:30:55

Four finalist teams will present their recommendations on subject company Colgate-Palmolive at CFA Institute Research Challenge New York Local Final New York, NY (PRWEB) February 11, 2014 The New York Society of Security Analysts (NYSSA) announced the selection of the four finalist teams for the New York Local Final of the CFA Institute Research Challenge®. The student teams will present their research to a panel of senior finance experts on February 20, 2014 from 6:00 p.m.–9:00...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related